J Korean Breast Cancer Soc.  1998 Jun;1(1):119-130. 10.4048/jkbcs.1998.1.1.119.

Breast Cancer of 35 Years Old or Less

Affiliations
  • 1Department of Seoul National University College of Medicine, Seoul Korea.

Abstract

The age of onset of Korean breast carcinoma is younger than that in western countries by some 10 years, thus the criteria of young age in manuscript from western countries cannot reflect the characteristics of young breast cancer properly in Korea. We studied 290 breast cancer patients, 35 years old or younger retrospectively. Jan. 1980 to Dec. 1995 in the Department of Surgery, Seoul National University Hospital. The age criteria of 30 and 35 years was utilized to define two groups. The group (age< or = 35) had larger primary tumors, more metastatic lymph nodes, and worse stages than older counterpart (p=0.015, 0.0066, 0.0329 respectively). They had worse disease-free survival but not overall survival (p=0.2427, 0.0312 respectively). The other group (age< or = 30) showed significantiy worse outcome in overall as well as disease free survival (p=0.0056, 0.0013) compared to the group (age>30). When we compared the group of age< or = 30 to that of 31< or = age< or = 35, there was statistically significant difference in primary tumor size, axillary nodal status and pathological stage (p=0.023, 0.019, 0.022 respectively). The age of 30 might be better criteria to define young age as prognostic factor rather than age of 35 in Korea.

Keyword

Age; Prognosis; Breast Cancer

MeSH Terms

Adult*
Age of Onset
Breast Neoplasms*
Breast*
Disease-Free Survival
Humans
Korea
Lymph Nodes
Prognosis
Retrospective Studies
Seoul

Cited by  1 articles

Clinical significance of age for premenopausal women with primary breast cancer
Byung-Mo Kang, Jin-Hyang Jung, Yang-Soo Lim, Ho-Yong Park, Young-Ha Lee
J Breast Cancer. 2006;9(4):323-329.    doi: 10.4048/jbc.2006.9.4.323.

Full Text Links
  • JKBCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr